Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Harms

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2015
Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathwaysFernando E Padovan-Neto, Stephen Sammut, Shreaya Chakroborty, et al.
Clinical & Experimental Metastasis|July 15, 2003
Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude miceAndrea Manni, Sharlene Washington, Laura Craig, et al.
Biomedicines|May 25, 2024
CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle DeliveryThomas Abraham, Michael Armold, Christopher McGovern, et al.
Cancer Biology & Therapy|January 27, 2012
A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancerJill P Smith, John F Harms, Gail L Matters, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 7, 2010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's diseaseRobin J Kleiman, Lida H Kimmel, Susan E Bove, et al.
Pancreas|May 26, 2009
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expressionGail L Matters, John F Harms, Christopher O McGovern, et al.
Cancer Research|August 17, 2005
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasisJennifer E Koblinski, Benjamin R Kaplan-Singer, Sherilyn J VanOsdol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Kinetics of metastatic breast cancer cell trafficking in bonePushkar A Phadke, Robyn R Mercer, John F Harms, et al.
Journal of Medicinal Chemistry|July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophreniaPatrick R Verhoest, Douglas S Chapin, Michael Corman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2012
Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivoRobin J Kleiman, Douglas S Chapin, Curt Christoffersen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2015
Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathwaysFernando E Padovan-Neto, Stephen Sammut, Shreaya Chakroborty, et al.
Clinical & Experimental Metastasis|July 15, 2003
Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude miceAndrea Manni, Sharlene Washington, Laura Craig, et al.
Biomedicines|May 25, 2024
CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle DeliveryThomas Abraham, Michael Armold, Christopher McGovern, et al.
Cancer Biology & Therapy|January 27, 2012
A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancerJill P Smith, John F Harms, Gail L Matters, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 7, 2010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's diseaseRobin J Kleiman, Lida H Kimmel, Susan E Bove, et al.
Pancreas|May 26, 2009
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expressionGail L Matters, John F Harms, Christopher O McGovern, et al.
Cancer Research|August 17, 2005
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasisJennifer E Koblinski, Benjamin R Kaplan-Singer, Sherilyn J VanOsdol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Kinetics of metastatic breast cancer cell trafficking in bonePushkar A Phadke, Robyn R Mercer, John F Harms, et al.
Journal of Medicinal Chemistry|July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophreniaPatrick R Verhoest, Douglas S Chapin, Michael Corman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2012
Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivoRobin J Kleiman, Douglas S Chapin, Curt Christoffersen, et al.
Pageof 3